Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they’re manageable.
Category: Kimberly-Clark Corporation
-
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm
The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
-
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm
The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
-
Kimberly-Clark to Buy Tylenol Maker Kenvue for $40 Billion
The owner of Kleenex and Huggies will acquire the company that has fought claims by the Trump administration that a common pain reliever is linked to harmful side effects.
-
Corporate America Has a Message for the Fed About Inflation
The New York Times – Business:If Federal Reserve Chair Jerome H. Powell and his colleagues look at company earnings reports, these themes might catch their eye.